sr-144528 and Skin-Diseases

sr-144528 has been researched along with Skin-Diseases* in 1 studies

Other Studies

1 other study(ies) available for sr-144528 and Skin-Diseases

ArticleYear
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease.
    European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

    A set of CB2R ligands, based on the thiophene scaffold, was synthesized and evaluated in in vitro assays. Compounds 8c-i, k, l, bearing the 3-carboxylate and 2-(adamantan-1-yl)carboxamido groups together with apolar alkyl/aryl substituents at 5-position or at 4- and 5-positions of the thiophene ring possess high CB2R affinity at low nanomolar concentration, good receptor selectivity, and agonistic functional activity. The full agonist 8g, showing the best balance between receptor affinity and selectivity, was tested in vitro in an experimental model of allergic contact dermatitis and proved to be able to block the release of MCP-2 in HaCaT cells at 10 μM concentration.

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Immunosuppressive Agents; Inflammation; Keratinocytes; Molecular Structure; Receptor, Cannabinoid, CB2; Skin Diseases; Structure-Activity Relationship; Thiophenes

2019